Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 420

1.

Admission hypoxia-inducible factor 1α levels and in-hospital mortality in patients with acute decompensated heart failure.

Li G, Lu WH, Wu XW, Cheng J, Ai R, Zhou ZH, Tang ZZ.

BMC Cardiovasc Disord. 2015 Jul 30;15(1):79. doi: 10.1186/s12872-015-0073-6.

2.

Challenging the two concepts in determining the appropriate pre-discharge N-terminal pro a brain natriuretic peptide treatment target in acute decompensated heart failure patients: absolute or relative discharge levels?

Stienen S, Salah K, Eurlings LW, Bettencourt P, Pimenta JM, Metra M, Bayes-Genis A, Verdiani V, Bettari L, Lazzarini V, Tijssen JP, Pinto YM, Kok WE.

Eur J Heart Fail. 2015 Jul 29. doi: 10.1002/ejhf.320. [Epub ahead of print]

PMID:
26222618
3.

Volume Overload in Heart Failure: An Evidence-Based Review of Strategies for Treatment and Prevention.

Houston BA, Kalathiya RJ, Kim DA, Zakaria S.

Mayo Clin Proc. 2015 Jul 16. pii: S0025-6196(15)00351-1. doi: 10.1016/j.mayocp.2015.05.002. [Epub ahead of print] Review.

PMID:
26189443
5.

The Dose-Dependent Effect of Nesiritide on Renal Function in Patients with Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Xiong B, Wang C, Yao Y, Huang Y, Tan J, Cao Y, Zou Y, Huang J.

PLoS One. 2015 Jun 24;10(6):e0131326. doi: 10.1371/journal.pone.0131326. eCollection 2015.

6.

Natriuretic peptides for the treatment of acute heart failure: a focus on nesiritide in recent clinical trials.

Fajardo J, Heywood JT, Patterson JH, Adams K, Chow SL.

Expert Rev Cardiovasc Ther. 2015 Jul;13(7):743-51. doi: 10.1586/14779072.2015.1051034. Epub 2015 May 31.

PMID:
26028173
7.

De novo acute heart failure and acutely decompensated chronic heart failure.

Hummel A, Empe K, Dörr M, Felix SB.

Dtsch Arztebl Int. 2015 Apr 24;112(17):298-310. doi: 10.3238/arztebl.2015.0298.

8.

Significance of Low Plasma Levels of Brain-Derived Neurotrophic Factor in Patients With Heart Failure.

Takashio S, Sugiyama S, Yamamuro M, Takahama H, Hayashi T, Sugano Y, Izumiya Y, Hokimoto S, Minamino N, Yasuda S, Anzai T, Ogawa H.

Am J Cardiol. 2015 Jul 15;116(2):243-9. doi: 10.1016/j.amjcard.2015.04.018. Epub 2015 Apr 18.

PMID:
25983281
9.

Role of Soluble ST2 as a Prognostic Marker in Patients with Acute Heart Failure and Renal Insufficiency.

Kim MS, Jeong TD, Han SB, Min WK, Kim JJ.

J Korean Med Sci. 2015 May;30(5):569-75. doi: 10.3346/jkms.2015.30.5.569. Epub 2015 Apr 15.

10.

Urine neutrophil gelatinase-associated lipocalin levels predict acute kidney injury in acute decompensated heart failure patients.

Soyler C, Tanriover MD, Ascioglu S, Aksu NM, Arici M.

Ren Fail. 2015 Apr 14:1-5. [Epub ahead of print]

PMID:
25869054
11.

Levosimendan and nesiritide as a combination therapy in patients with acute heart failure.

Jia Z, Guo M, Zhang LY, Zhang YQ, Liang HQ, Song Y.

Am J Med Sci. 2015 May;349(5):398-405. doi: 10.1097/MAJ.0000000000000461.

PMID:
25853935
12.

Nesiritide is beneficial or harmful to patients with decompensated acute congestive heart failure.

Ma X, Sun F, Ma J.

Int J Cardiol. 2015 May 6;187:387-8. doi: 10.1016/j.ijcard.2015.03.287. Epub 2015 Mar 20. No abstract available.

PMID:
25841132
15.

Assessment of respiratory disturbance index determined with a non-restrictive monitor and of autonomic nervous system parameters in heart failure patients: A pilot study.

Shimazu S, Hirashiki A, Kamimura Y, Nakano Y, Adachi S, Kondo T, Murohara T.

J Cardiol. 2015 Feb 3. pii: S0914-5087(15)00011-8. doi: 10.1016/j.jjcc.2014.12.018. [Epub ahead of print]

PMID:
25662622
16.

Diagnostic performance of cardiopulmonary ultrasound performed by the emergency physician in the management of acute dyspnea.

Gallard E, Redonnet JP, Bourcier JE, Deshaies D, Largeteau N, Amalric JM, Chedaddi F, Bourgeois JM, Garnier D, Geeraerts T.

Am J Emerg Med. 2015 Mar;33(3):352-8. doi: 10.1016/j.ajem.2014.12.003. Epub 2014 Dec 11.

PMID:
25572643
17.

Dynamic changes in bioelectrical impedance vector analysis and phase angle in acute decompensated heart failure.

Alves FD, Souza GC, Aliti GB, Rabelo-Silva ER, Clausell N, Biolo A.

Nutrition. 2015 Jan;31(1):84-9. doi: 10.1016/j.nut.2014.05.004. Epub 2014 May 29.

PMID:
25466653
18.

Acute decompensated heart failure patients admitted to critical care units: insights from ASCEND-HF.

van Diepen S, Podder M, Hernandez AF, Westerhout CM, Armstong PW, McMurray JJ, Eapen ZJ, Califf RM, Starling RC, O'Connor CM, Ezekowitz JA.

Int J Cardiol. 2014 Dec 20;177(3):840-6. doi: 10.1016/j.ijcard.2014.11.007. Epub 2014 Nov 4.

PMID:
25465830
19.

Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trial.

Tang WH, Dupont M, Hernandez AF, Voors AA, Hsu AP, Felker GM, Butler J, Metra M, Anker SD, Troughton RW, Gottlieb SS, McMurray JJ, Armstrong PW, Massie BM, Califf RM, O'Connor CM, Starling RC.

JACC Heart Fail. 2015 Jan;3(1):40-9. doi: 10.1016/j.jchf.2014.06.014. Epub 2014 Nov 11.

PMID:
25453534
20.

The effects of fusion structure on the expression and bioactivity of human brain natriuretic peptide (BNP) albumin fusion proteins.

Ding Y, Peng Y, Deng L, Wu Y, Fu Q, Jin J.

Curr Pharm Biotechnol. 2014;15(9):856-63.

PMID:
25307015
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk